BioCentury
ARTICLE | Clinical News

Alexion regulatory update

June 10, 1996 7:00 AM UTC

ALXN said U.S. Patent No. 5,523,226 issued, covering the composition of porcine embryonic stem cells. The patent, held by Biotechnology Research and Development Corp., is exclusively licensed to ALXN ...